Related references
Note: Only part of the references are listed.Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease
Pratishtha Chatterjee et al.
TRANSLATIONAL PSYCHIATRY (2021)
Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma
Simon Lovestone et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study
Frank de Wolfa et al.
BRAIN (2020)
Blood Biomarkers: Democratizing Alzheimer's Diagnostics
Henrik Zetterberg et al.
NEURON (2020)
Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona
John E. Blume et al.
NATURE COMMUNICATIONS (2020)
Nano-scavengers for blood biomarker discovery in ovarian carcinoma
Marilena Hadjidemetriou et al.
NANO TODAY (2020)
Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood
Yi Ju et al.
ACS NANO (2020)
The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA
Lois Gardner et al.
NANOSCALE HORIZONS (2020)
Relationship of amyloid-β1-42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study
Oscar L. Lopez et al.
BRAIN COMMUNICATIONS (2020)
Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation
Lana Papafilippou et al.
NANOSCALE (2020)
The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
Pierre Dourlen et al.
ACTA NEUROPATHOLOGICA (2019)
The rights of precision drug development for Alzheimer's disease
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study
Marilena Hadjidemetriou et al.
ADVANCED MATERIALS (2019)
A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona
Marilena Hadjidemetriou et al.
BIOMATERIALS (2019)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation et al.
NATURE MEDICINE (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease
Marta Mila-Aloma et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Molecular biomarkers of Alzheimer's disease: progress and prospects
Tammaryn Lashley et al.
DISEASE MODELS & MECHANISMS (2018)
A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations
Steven J. Kiddle et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
Liu Shi et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes
Zahraa S. Al-Ahmady et al.
JOURNAL OF CONTROLLED RELEASE (2018)
In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape
Rafaela Garcia-Alvarez et al.
NANOSCALE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Levels of ADAM10 are reduced in Alzheimer's disease CSF
Aitana Sogorb-Esteve et al.
JOURNAL OF NEUROINFLAMMATION (2018)
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers
Emma Lawrence et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Jun Wang et al.
Nature Reviews Neurology (2017)
On the path to 2025: understanding the Alzheimer's disease continuum
Paul S. Aisen et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles
Marilena Hadjidemetriou et al.
NANOSCALE (2016)
Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease
Dejiang Wang et al.
NEUROREPORT (2016)
Alzheimer's disease: are blood and brain markers related? A systematic review
Ali T. Khan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges
Bruno Dubois et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles
Marilena Hadjidemetriou et al.
ACS NANO (2015)
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Alison L. Baird et al.
FRONTIERS IN NEUROLOGY (2015)
Developing novel blood-based biomarkers for Alzheimer's disease
Heather M. Snyder et al.
ALZHEIMERS & DEMENTIA (2014)
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats
J. R. Rivers-Auty et al.
NEUROSCIENCE LETTERS (2014)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Stefan Tenzer et al.
NATURE NANOTECHNOLOGY (2013)
Plasma tau levels in Alzheimer's disease
Henrik Zetterberg et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
Maria I. Fonseca et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium
Timothy R. Mhyre et al.
NEUROBIOLOGY OF AGING (2008)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
α-secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients
F Colciaghi et al.
MOLECULAR MEDICINE (2002)
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
JL Jankowsky et al.
BIOMOLECULAR ENGINEERING (2001)
Share Paper
